Bank of America’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $144M | Buy |
490,412
+45,455
| +10% | +$12.9M | 0.01% | 954 |
|
|
2026
Q1 | $124M | Sell |
444,957
-492
| -0.1% | -$142K | 0.01% | 971 |
|
|
2025
Q4 | $135M | Sell |
445,449
-14,438
| -3% | -$4.51M | 0.01% | 936 |
|
|
2025
Q3 | $129M | Buy |
459,887
+7,754
| +2% | +$2.11M | 0.01% | 1052 |
|
|
2025
Q2 | $109M | Buy |
452,133
+21,594
| +5% | +$5.1M | 0.01% | 1095 |
|
|
2025
Q1 | $105M | Buy |
430,539
+3,247
| +0.8% | +$977K | 0.01% | 1049 |
|
|
2024
Q4 | $140M | Sell |
427,292
-44,740
| -9% | -$15.2M | 0.01% | 851 |
|
|
2024
Q3 | $158M | Buy |
472,032
+30,156
| +7% | +$9.58M | 0.01% | 843 |
|
|
2024
Q2 | $121M | Buy |
441,876
+67,994
| +18% | +$19.8M | 0.01% | 913 |
|
|
2024
Q1 | $129M | Sell |
373,882
-13,911
| -4% | -$4.57M | 0.01% | 894 |
|
|
2023
Q4 | $125M | Sell |
387,793
-108,845
| -22% | -$34.1M | 0.01% | 843 |
|
|
2023
Q3 | $178M | Buy |
496,638
+49,181
| +11% | +$19M | 0.02% | 636 |
|
|
2023
Q2 | $170M | Sell |
447,457
-12,758
| -3% | -$5.19M | 0.02% | 658 |
|
|
2023
Q1 | $220M | Buy |
460,215
+51,419
| +13% | +$24.1M | 0.02% | 591 |
|
|
2022
Q4 | $172M | Sell |
408,796
-1,270
| -0.3% | -$513K | 0.02% | 657 |
|
|
2022
Q3 | $171M | Buy |
410,066
+2,474
| +0.6% | +$1.23M | 0.02% | 638 |
|
|
2022
Q2 | $202M | Buy |
407,592
+13,093
| +3% | +$6.82M | 0.02% | 584 |
|
|
2022
Q1 | $222M | Buy |
394,499
+23,848
| +6% | +$14.4M | 0.02% | 608 |
|
|
2021
Q4 | $280M | Sell |
370,651
-11,420
| -3% | -$8.55M | 0.03% | 534 |
|
|
2021
Q3 | $285M | Sell |
382,071
-16,129
| -4% | -$12.1M | 0.03% | 507 |
|
|
2021
Q2 | $257M | Buy |
398,200
+27,439
| +7% | +$16.7M | 0.03% | 532 |
|
|
2021
Q1 | $212M | Buy |
370,761
+5,665
| +2% | +$3.35M | 0.02% | 561 |
|
|
2020
Q4 | $213M | Sell |
365,096
-19,048
| -5% | -$10.8M | 0.03% | 502 |
|
|
2020
Q3 | $198M | Buy |
384,144
+35,764
| +10% | +$18.1M | 0.03% | 497 |
|
|
2020
Q2 | $157M | Buy |
348,380
+5,847
| +2% | +$2.58M | 0.02% | 537 |
|
|
2020
Q1 | $120M | Sell |
342,533
-25,644
| -7% | -$9.43M | 0.02% | 570 |
|
|
2019
Q4 | $136M | Buy |
368,177
+41,375
| +13% | +$14.6M | 0.02% | 633 |
|
|
2019
Q3 | $109M | Buy |
326,802
+10,300
| +3% | +$3.36M | 0.02% | 695 |
|
|
2019
Q2 | $98.9M | Sell |
316,502
-5,293
| -2% | -$1.58M | 0.02% | 737 |
|
|
2019
Q1 | $98.4M | Buy |
321,795
+34,592
| +12% | +$9.33M | 0.02% | 748 |
|
|
2018
Q4 | $66.7M | Sell |
287,203
-45,637
| -14% | -$12.2M | 0.01% | 845 |
|
|
2018
Q3 | $104M | Sell |
332,840
-1,429
| -0.4% | -$444K | 0.02% | 706 |
|
|
2018
Q2 | $96.5M | Sell |
334,269
-7,432
| -2% | -$2.05M | 0.02% | 714 |
|
|
2018
Q1 | $85.5M | Buy |
341,701
+11,283
| +3% | +$2.87M | 0.01% | 772 |
|
|
2017
Q4 | $78.9M | Sell |
330,418
-193,461
| -37% | -$46.9M | 0.01% | 842 |
|
|
2017
Q3 | $116M | Buy |
523,879
+170,370
| +48% | +$38.3M | 0.02% | 686 |
|
|
2017
Q2 | $80M | Sell |
353,509
-12,400
| -3% | -$2.7M | 0.02% | 795 |
|
|
2017
Q1 | $72.9M | Sell |
365,909
-22,464
| -6% | -$4.33M | 0.01% | 844 |
|
|
2016
Q4 | $70.8M | Buy |
388,373
+45,049
| +13% | +$7.68M | 0.02% | 828 |
|
|
2016
Q3 | $56.2M | Buy |
343,324
+12,945
| +4% | +$1.96M | 0.01% | 907 |
|
|
2016
Q2 | $47.3M | Buy |
330,379
+5,949
| +2% | +$849K | 0.01% | 1014 |
|
|
2016
Q1 | $44.4M | Sell |
324,430
-153
| -0% | -$20.1K | 0.01% | 998 |
|
|
2015
Q4 | $45M | Buy |
324,583
+3,713
| +1% | +$515K | 0.01% | 1060 |
|
|
2015
Q3 | $43.1M | Buy |
320,870
+254,880
| +386% | +$36.7M | 0.01% | 1068 |
|
|
2015
Q2 | $9.94M | Buy |
65,990
+10,704
| +19% | +$1.53M | ﹤0.01% | 1934 |
|
|
2015
Q1 | $7.47M | Buy |
55,286
+2,195
| +4% | +$272K | ﹤0.01% | 2122 |
|
|
2014
Q4 | $6.4M | Buy |
53,091
+1,254
| +2% | +$144K | ﹤0.01% | 2333 |
|
|
2014
Q3 | $5.88M | Buy |
51,837
+2,915
| +6% | +$345K | ﹤0.01% | 2415 |
|
|
2014
Q2 | $5.86M | Buy |
48,922
+5,551
| +13% | +$678K | ﹤0.01% | 2419 |
|
|
2014
Q1 | $5.56M | Sell |
43,371
-4,232
| -9% | -$542K | ﹤0.01% | 2295 |
|
|
2013
Q4 | $5.88M | Sell |
47,603
-7,628
| -14% | -$930K | ﹤0.01% | 2329 |
|
|
2013
Q3 | $6.49M | Buy |
55,231
+1,503
| +3% | +$177K | ﹤0.01% | 2171 |
|
|
2013
Q2 | $6.03M | Buy |
+53,728
| New | +$6.3M | ﹤0.01% | 2140 |
|
Other funds holding BIO
AI
Bank of America's BIO Position: Q2 2026 in Review
Bank of America increased its Bio-Rad Laboratories Class A (BIO) stake by 10% in Q2 2026, buying an estimated $12.9M and bringing the position to 490,412 shares worth $144M. The position accounts for 0.01% of the portfolio, ranked #954.
Bank of America first reported a position in BIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $285M in Q3 2021. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Bank of America held 490,412 shares of Bio-Rad Laboratories Class A worth $144M as of Q2 2026.
- Bank of America bought 45,455 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $12.9M.
- Bio-Rad Laboratories Class A made up 0.01% of Bank of America's portfolio in Q2 2026, its #954 holding.
- Bank of America first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 53 quarters since.
- Bank of America's Bio-Rad Laboratories Class A position peaked at $285M in Q3 2021.
- 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.